India’s Strategic Stance on the WHO Pandemic Treaty: Balancing Sovereignty and Global Health Equity
GS2GS3
As negotiations for the WHO Pandemic Agreement continue, India is advocating for a framework that prioritizes technology transfer, supply-chain autonomy, and equitable access to medical countermeasures.
The ongoing negotiations for the World Health Organization (WHO) Pandemic Agreement represent a critical juncture in global health governance. In 2026, as the international community seeks to formalize a collaborative mechanism to mitigate future health emergencies, India has emerged as a pivotal negotiator. The Indian position is built on a nuanced understanding of national sovereignty, emphasizing that global mandates must not infringe upon domestic policy space, particularly concerning the regulation of pharmaceutical production and healthcare infrastructure.
Central to India's argument is the 'Global South' perspective on equity. During the past pandemic, the global health architecture faced severe criticism for the hoarding of vaccines and essential medical equipment by developed nations. To address this, India is pushing for a mandatory, rather than voluntary, framework for the transfer of technology and intellectual property rights. This is vital to ensure that developing nations can scale up domestic manufacturing during crises, thereby reducing reliance on global supply chains that have historically proven fragile and prone to disruption.
Continue reading — free with login
JeetoBharat publishes daily UPSC current affairs mapped to the Mains syllabus. Log in to read full articles.
Log in to read full articleNo credit card required. Free registered users get unlimited access.
This article was curated using AI. While we strive for accuracy, please verify critical facts from official sources.